Yousif Capital Management LLC Sells 798 Shares of Encompass Health Corporation $EHC

Yousif Capital Management LLC reduced its stake in Encompass Health Corporation (NYSE:EHC) by 2.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,902 shares of the company’s stock after selling 798 shares during the period. Yousif Capital Management LLC’s holdings in Encompass Health were worth $4,403,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Invesco Ltd. boosted its stake in Encompass Health by 5.1% during the first quarter. Invesco Ltd. now owns 5,818,783 shares of the company’s stock valued at $589,326,000 after buying an additional 282,532 shares during the period. T. Rowe Price Investment Management Inc. boosted its stake in Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock valued at $210,756,000 after buying an additional 424,691 shares during the period. Dimensional Fund Advisors LP boosted its stake in Encompass Health by 5.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company’s stock valued at $189,549,000 after buying an additional 93,992 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Encompass Health by 13.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company’s stock valued at $184,571,000 after buying an additional 211,707 shares during the period. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in Encompass Health by 11.9% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,541,477 shares of the company’s stock valued at $156,121,000 after buying an additional 163,400 shares during the period. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several research analyst reports. Truist Financial lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. UBS Group lifted their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Bank of America raised their price target on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Finally, KeyCorp raised their price target on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Tuesday, September 16th. One research analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $139.86.

Encompass Health Trading Up 0.5%

NYSE EHC opened at $123.53 on Thursday. The company has a market capitalization of $12.44 billion, a price-to-earnings ratio of 24.17, a PEG ratio of 2.15 and a beta of 0.93. The stock’s 50-day simple moving average is $123.28 and its two-hundred day simple moving average is $116.84. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.86.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a $0.19 dividend. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Wednesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 14.87%.

Insider Activity at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.